0     

Chen TX, Casey HL, Lin CR, Boyle TA, Schmahmann JD, L'Italien GJ, et al. Early-life social determinants of SCA6 age at onset, severity, and progression. Cerebellum. 2024;:. PMID: 38217689.

0     

Lin CR, Kuo SH, Opal P. Cognitive, emotional, and other non-motor symptoms of spinocerebellar ataxias. Curr Neurol Neurosci Rep. 2024;24(3):47-54. PMID: 38270820.

0     

Rampalli I, Pavlik VN, Yu MM, Bishop J, Lin CR. Cognitive function remains associated with functional impairment in profound dementia: Alzheimer disease and dementia with Lewy bodies. Neurol Clin Pract. 2024;14(2):e200262. PMID: 38322828.

0     

Baker LD, Snyder HM, Espeland MA, Whitmer RA, Kivipelto M, Woolard N, et al. Study design and methods: U.S. study to protect brain health through lifestyle intervention to reduce risk (U.S. POINTER). Alzheimers Dement. 2023;20(2):769-82. PMID: 37776210.

0     

Lai RY, Desai NA, Amlang CJ, Lin CR, Chen TX, Minyetty MJ, et al. Gambling associated risk-taking decision in cerebellar ataxia. Parkinsonism Relat Disord. 2023;107:105252. PMID: 36577359.

0     

Lin CR, Amokrane N, Chen S, Chen TX, Lai RY, Trinh P, et al. Cerebellar impulsivity-compulsivity assessment scale. Ann Clin Transl Neurol. 2023;10(1):48-57. PMID: 36401598.

0     

Lin CR, Kuo SH. Ataxias: Hereditary, acquired, and reversible etiologies. Semin Neurol. 2023;43(1):48-64. PMID: 36828010.

0     

Ngan E, Chan W, Leon-Novelo L, Pavlik V. Estimation of non-monotonic transition rates in a semi-Markov process with covariates adjustments and application to caregivers' stress data. Stat Med. 2023;42(30):5646-56. PMID: 37807023.

0     

Nicholas J, Amlang C, Lin CR, Montaser-Kouhsari L, Desai N, Pan MK, et al. The role of the cerebellum in learning to predict reward: Evidence from cerebellar ataxia. Cerebellum. 2023;:. PMID: 38066397.

0     

Chen TX, Lin CYR, Aumann MA, Yan Y, Amokrane N, Desai NA, et al. Impulsivity trait profiles in patients with cerebellar ataxia and Parkinson disease. Neurology. 2022;99(2):e176-86. PMID: 35428731.

0     

Cohen HS, Lincoln CM, Pavlik VN, Sangi-Haghpeykar H. Changes in measures of vestibular and balance function and hippocampus volume in Alzheimer's disease and mild cognitive impairment. Otol Neurotol. 2022;43(6):e663-70. PMID: 35761460.

0     

Lin CR, Viswanathan A, Chen TX, Mitsumoto H, Vonsattel JP, Faust PL, et al. Clinicopathological correlates of pyramidal signs in multiple system atrophy. Ann Clin Transl Neurol. 2022;9(7):988-94. PMID: 35593123.

0     

Ostrowitzki S, Bittner T, Sink KM, Mackey H, Rabe C, Honig LS, et al. Evaluating the safety and efficacy of crenezumab vs placebo in adults with early Alzheimer disease: Two phase 3 randomized placebo-controlled trials. JAMA Neurol. 2022;79(11):1113-21. PMID: 36121669.

0     

Pavlik VN, Burnham SC, Kass JS, Helmer C, Palmqvist S, Vassilaki M, et al. Connecting Cohorts to Diminish Alzheimer's Disease (CONCORD-AD): A report of an international research collaboration network. J Alzheimers Dis. 2022;85(1):31-45. PMID: 34776434.

0     

Fu X, Yu W, Ke M, Wang X, Zhang J, Luo T, et al. Chinese version of the Baylor Profound Mental Status Examination: A brief staging measure for patients with severe Alzheimer's disease. J Prev Alzheimers Dis. 2021;8(2):175-80. PMID: 33569564.

0     

Roy Lin CY, Rosendale N, Deeb W. Expanding sexual and gender minority research in movement disorders: More than awareness and acceptance. Parkinsonism Relat Disord. 2021;87:162-5. PMID: 34088617.

0     

Sood A, Pavlik V, Darby E, Chan W, Doody R. Different cognitive profiles are associated with progression rate and age at death in probable Alzheimer's disease. J Alzheimers Dis. 2021;80(2):735-47. PMID: 33579838.

0     

Amokrane N, Lin CR, Desai NA, Kuo SH. The impact of compulsivity and impulsivity in cerebellar ataxia: A case series. Tremor Other Hyperkinet Mov (N Y). 2020;10:43. PMID: 33133767.

0     

Amokrane N, Viswanathan A, Freedman S, Yang CY, Desai NA, Pan MK, et al. Impulsivity in cerebellar ataxias: Testing the cerebellar reward hypothesis in humans. Mov Disord. 2020;35(8):1491-3. PMID: 32497310.

0     

Lin CY, Chen CH, Tom SE, Kuo SH, Alzheimer's Disease Neuroimaging Initiative. Cerebellar volume is associated with cognitive decline in mild cognitive impairment: Results from ADNI. Cerebellum. 2020;19(2):217-25. PMID: 31900856.

0     

Szigeti K, Ihnatovych I, Birkaya B, Chen Z, Ouf A, Indurthi DC, et al. CHRFAM7A: A human specific fusion gene, accounts for the translational gap for cholinergic strategies in Alzheimer's disease. EBioMedicine. 2020;59:102892. PMID: 32818803.

0     

Yang CY, Lai RY, Amokrane N, Lin CY, Figueroa KP, Pulst SM, et al. Dysphagia in spinocerebellar ataxias type 1, 2, 3 and 6. J Neurol Sci. 2020;415:116878. PMID: 32454319.

11

Marafi D, Suter B, Schultz R, Glaze D, Pavlik VN, Goldman AM. Spectrum and time course of epilepsy and the associated cognitive decline in MECP2 duplication syndrome. Neurology. 2019;92(2):e108-14. PMID: 30552298.

3

Pavlik VN, Chan W, Darby E. Cohort effects in progression rate on cognitive and functional measures in an Alzheimer's disease clinical cohort. J Alzheimers Dis. 2019;71(2):659-69. PMID: 31424408.

5

Balsis S, Geraci L, Benge J, Lowe DA, Choudhury TK, Tirso R, et al. Statistical model of dynamic markers of the Alzheimer's pathological cascade. J Gerontol B Psychol Sci Soc Sci. 2018;73(6):964-73. PMID: 29741663.

0     

Lin CY, Wang MJ, Tse W, Pinotti R, Alaedini A, Green PHR, et al. Serum antigliadin antibodies in cerebellar ataxias: A systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2018;89(11):1174-80. PMID: 29866704.

13

Woodward MR, Hafeez MU, Qi Q, Riaz A, Benedict RHB, Yan L, et al. Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging. Am J Geriatr Psychiatry. 2018;26(8):835-46. PMID: 29858162.

0     

Hyman DJ, Pavlik V. Controlling hypertension: We have the tools-we just need to use them. J Gen Intern Med. 2017;32(8):860-2. PMID: 28455646.

15

Jia J, Wei C, Jia L, Tang Y, Liang J, Zhou A, et al. Efficacy and safety of donepezil in Chinese patients with severe Alzheimer's disease: A randomized controlled trial. J Alzheimers Dis. 2017;56(4):1495-504. PMID: 28157100.

0     

Kuo SH, Lin CY, Wang J, Sims PA, Pan MK, Liou JY, et al. Climbing fiber-Purkinje cell synaptic pathology in tremor and cerebellar degenerative diseases. Acta Neuropathol. 2017;133(1):121-38. PMID: 27704282.

45

Li K, Chan W, Doody RS, Quinn J, Luo S, Alzheimer's Disease Neuroimaging Initiative. Prediction of conversion to Alzheimer's disease with longitudinal measures and time-to-event data. J Alzheimers Dis. 2017;58(2):361-71. PMID: 28436391.

0     

Lin CY, Kuo SH. Cerebellar ataxia and hearing impairment. JAMA Neurol. 2017;74(2):243-4. PMID: 27918770.

0     

Lin CY, Kuo SH. The role of the cerebellum in rock climbing. J Neurol Sci. 2017;383:158-60. PMID: 29246605.

0     

Lin CY, Yoo JY, Doshi A, Colman R. Clinical reasoning: A 61-year-old man with conjugate gaze deviation, hemiparesis, and asymmetric reflexes. Neurology. 2017;89(9):e105-8. PMID: 28847838.

22

Nave S, Doody RS, Boada M, Grimmer T, Savola JM, Delmar P, et al. Sembragiline in moderate Alzheimer's disease: Results of a randomized, double-blind, placebo-controlled phase ii trial (MAyflOwer RoAD). J Alzheimers Dis. 2017;58(4):1217-28. PMID: 28550255.

43

Woodward MR, Amrutkar CV, Shah HC, Benedict RH, Rajakrishnan S, Doody RS, et al. Validation of olfactory deficit as a biomarker of Alzheimer disease. Neurol Clin Pract. 2017;7(1):5-14. PMID: 28243501.

17

Zimmerman RK, Brown AE, Pavlik VN, Moehling KK, Raviotta JM, Lin CJ, et al. Using the 4 pillars practice transformation program to increase pneumococcal immunizations for older adults: a cluster-randomized trial. J Am Geriatr Soc. 2017;65(1):114-22. PMID: 27755655.

3

Alverson WA, Massman PJ, Doody RS. Prevalence and correlates of cognitive asymmetry in a large sample of Alzheimer's disease patients. J Clin Exp Neuropsychol. 2016;38(5):516-26. PMID: 26757777.

12

Bang J, Lobach IV, Lang AE, Grossman M, Knopman DS, Miller BL, et al. Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials. Parkinsonism Relat Disord. 2016;28:41-8. PMID: 27172829.

6

Benoit JS, Chan W, Luo S, Yeh HW, Doody R. A hidden Markov model approach to analyze longitudinal ternary outcomes when some observed states are possibly misclassified. Stat Med. 2016;35(9):1549-57. PMID: 26782946.

4

Doody RS, D'Amico S, Cutler AJ, Davis CS, Shin P, Ledon F, et al. An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results. CNS Spectr. 2016;21(6):450-9. PMID: 26471212.

11

Gordon MF, Lenderking WR, Duhig A, Chandler J, Lundy JJ, Miller DS, et al. Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase. Alzheimers Dement. 2016;12(1):75-84. PMID: 26079412.

3

Hammond FM, Alexander DN, Cutler AJ, D'Amico S, Doody RS, Sauve W, et al. Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC Neurol. 2016;16(1):160. PMID: 27590297.

20

Hammond FM, Alexander DN, Cutler AJ, D'Amico S, Doody RS, Sauve W, et al. PRISM II: An open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC Neurol. 2016;16(1):89. PMID: 27276999.

0     

Kuo SH, Lin CY, Wang J, Liou JY, Pan MK, Louis RJ, et al. Deep brain stimulation and climbing fiber synaptic pathology in essential tremor. Ann Neurol. 2016;80(3):461-5. PMID: 27422481.

4

Liang FW, Chan W, Chen PJ, Zimmerman C, Waring S, Doody R. Cognitively-related basic activities of daily living impairment greatly increases the risk of death in Alzheimers disease. PLoS One. 2016;11(8):e0160671. PMID: 27571265.

16

Lin CJ, Nowalk MP, Pavlik VN, Brown AE, Zhang S, Raviotta JM, et al. Using the 4 pillars practice transformation program to increase adult influenza vaccination and reduce missed opportunities in a randomized cluster trial. BMC Infect Dis. 2016;16(1):623. PMID: 27809793.

5

Luo S, Chan W, Detry MA, Massman PJ, Doody RS. Binomial regression with a misclassified covariate and outcome. Stat Methods Med Res. 2016;25(1):101-17. PMID: 22421539.

10

Nowalk MP, Lin CJ, Pavlik VN, Brown AE, Zhang S, Moehling KK, et al. Using the 4 pillars practice transformation program to increase adult Tdap immunization in a randomized controlled cluster trial. Vaccine. 2016;34(41):5026-33. PMID: 27576073.

9

Doody RS, Demirovic J, Ballantyne CM, Chan W, Barber R, Powell S, et al. Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease. Alzheimers Dement (Amst). 2015;1(4):464-71. PMID: 27239525.

21

Doody RS, Raman R, Sperling RA, Seimers E, Sethuraman G, Mohs R, et al. Peripheral and central effects of gamma-secretase inhibition by semagacestat in Alzheimer's disease. Alzheimers Res Ther. 2015;7(1):36. PMID: 26064192.

16

Grill JD, Raman R, Ernstrom K, Aisen P, Dowsett SA, Chen YF, et al. Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials. Alzheimers Res Ther. 2015;7(1):39. PMID: 26120368.

15

Henley DB, Dowsett SA, Chen YF, Liu-Seifert H, Grill JD, Doody RS, et al. Alzheimer's disease progression by geographical region in a clinical trial setting. Alzheimers Res Ther. 2015;7(1):43. PMID: 26120369.

33

Hyman DJ, Pavlik V. Medication adherence and resistant hypertension. J Hum Hypertens. 2015;29(4):213-8. PMID: 25209307.

27

Liu-Seifert H, Siemers E, Holdridge KC, Andersen SW, Lipkovich I, Carlson C, et al. Delayed-start analysis: Mild Alzheimer's disease patients in solanezumab trials, 3.5 years. Alzheimers Dement (N Y). 2015;1(2):111-21. DOI: 10.1016/j.trci.2015.06.006.

0     

Lo RY, Figueroa KP, Pulst SM, Lin CY, Perlman S, Wilmot G, et al. Coenzyme Q10 and spinocerebellar ataxias. Mov Disord. 2015;30(2):214-20. PMID: 25449974.

0     

Lo RY, Figueroa KP, Pulst SM, Lin CY, Perlman S, Wilmot G, et al. Vascular risk factors and clinical progression in spinocerebellar ataxias. Tremor Other Hyperkinet Mov (N Y). 2015;5:287. PMID: 25713748.

0     

Louis RJ, Lin CY, Faust PL, Koeppen AH, Kuo SH. Climbing fiber synaptic changes correlate with clinical features in essential tremor. Neurology. 2015;84(22):2284-6. PMID: 25948728.

6

Lowe DA, Balsis S, Benge JF, Doody RS. Adding delayed recall to the ADAS-cog improves measurement precision in mild Alzheimer's disease: Implications for predicting instrumental activities of daily living. Psychol Assess. 2015;27(4):1234-40. PMID: 25938338.

12

Pavlik VN, Chan W, Hyman DJ, Feldman P, Ogedegbe G, Schwartz JE, et al. Designing and evaluating health systems level hypertension control interventions for African-Americans: Lessons from a pooled analysis of three cluster randomized trials. Curr Hypertens Rev. 2015;11(2):123-31. PMID: 25808682.

0     

Rydz D, Lin CY, Xie T, Cortes E, Vonsattel JP, Kuo SH. Pathological findings of anti-Yo cerebellar degeneration with Holmes tremor. J Neurol Neurosurg Psychiatry. 2015;86(1):121-2. PMID: 24876186.

4

Salmeron S, Huedo I, Lopez-Utiel M, Soler-Moratalla I, Flores-Ruano T, Fernandez-Sanchez M, et al. Validation of the Spanish Version of the Baylor Profound Mental Status Examination. J Alzheimers Dis. 2015;49(1):73-8. PMID: 26444781.

0     

Vellas B, Bateman R, Blennow K, Frisoni G, Johnson K, Katz R, et al. Endpoints for pre-dementia ad trials: A report from the EU/US/CTAD task force. J Prev Alz Dis. 2015;2(2):128-35.

178

Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, et al. Davunetide in patients with progressive supranuclear palsy: A randomised, double-blind, placebo-controlled phase 2/3 trial. Lancet Neurol. 2014;13(7):676-85. PMID: 24873720.

0     

Chen TB, Lin CY, Lin KN, Yeh YC, Chen WT, Wang KS, et al. Culture qualitatively but not quantitatively influences performance in the Boston Naming Test in a Chinese-speaking population. Dement Geriatr Cogn Dis Extra. 2014;4(1):86-94. PMID: 24847347.

0     

Cohen HS, Mulavara AP, Sangi-Haghpeykar H, Peters BT, Bloomberg JJ, Pavlik VN. Screening people in the waiting room for vestibular impairments. South Med J. 2014;107(9):549-53. PMID: 25188617.

41

Doody RS, Farlow M, Aisen PS, Alzheimer's Disease Cooperative Study Data Analysis and Publication Committee. Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease. N Engl J Med. 2014;370(15):1460. PMID: 24716687.

949

Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med. 2014;370(4):311-21. PMID: 24450890.

0     

Lee M, Cheng MM, Lin CY, Louis ED, Faust PL, Kuo SH. Decreased EAAT2 protein expression in the essential tremor cerebellar cortex. Acta Neuropathol Commun. 2014;2:157. PMID: 25391854.

0     

Lin CY, Chen TB, Lin KN, Yeh YC, Chen WT, Wang KS, et al. Confrontation naming errors in Alzheimer's disease. Dement Geriatr Cogn Disord. 2014;37(1-2):86-94. PMID: 24107364.

0     

Lin CY, Louis ED, Faust PL, Koeppen AH, Vonsattel JP, Kuo SH. Abnormal climbing fibre-Purkinje cell synaptic connections in the essential tremor cerebellum. Brain. 2014;137(Pt 12):3149-59. PMID: 25273997.

9

O'Bryant SE, Xiao G, Barber R, Cullum CM, Weiner M, Hall J, et al. Molecular neuropsychology: Creation of test-specific blood biomarker algorithms. Dement Geriatr Cogn Disord. 2014;37(1-2):45-57. PMID: 24107792.

27

Pavlik V, Brown AE, Nash S, Gossey JT. Association of patient recall, satisfaction, and adherence to content of an electronic health record (EHR)-generated after visit summary: A randomized clinical trial. J Am Board Fam Med. 2014;27(2):209-18. PMID: 24610183.

11

Szigeti K, Kellermayer B, Lentini JM, Trummer B, Lal D, Doody RS, et al. Ordered subset analysis of copy number variation association with age at onset of Alzheimer's disease. J Alzheimers Dis. 2014;41(4):1063-71. PMID: 24787912.

5

Brown AE, Pavlik VN. Patient-centered research happens in practice-based research networks. J Am Board Fam Med. 2013;26(5):481-3. PMID: 24004698.

13

Brown AE, Tonigan JS, Pavlik VN, Kosten TR, Volk RJ. Spirituality and confidence to resist substance use among celebrate recovery participants. J Relig Health. 2013;52(1):107-13. PMID: 21246280.

5

Doody RS, Aisen PS, Iwatsubo T. Semagacestat for treatment of Alzheimer's disease. N Engl J Med. 2013;369(17):1661. PMID: 24152267.

709

Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med. 2013;369(4):341-50. PMID: 23883379.

10

Ferris S, Cummings J, Christensen D, Doody R, Farlow M, Sabbagh M, et al. Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: Evaluating the impact of baseline severity. Alzheimers Res Ther. 2013;5(1):12. PMID: 23433097.

27

Grigoryan L, Pavlik VN, Hyman DJ. Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence. J Am Soc Hypertens. 2013;7(6):471-6. PMID: 23890931.

13

Grigoryan L, Pavlik VN, Hyman DJ. Patterns of nonadherence to antihypertensive therapy in primary care. J Clin Hypertens (Greenwich). 2013;15(2):107-11. PMID: 23339728.

32

Mansyur CL, Pavlik VN, Hyman DJ, Taylor WC, Goodrick GK. Self-efficacy and barriers to multiple behavior change in low-income African Americans with hypertension. J Behav Med. 2013;36(1):75-85. PMID: 22322910.

0     

O'Bryant SE, Johnson L, Edwards M, Soares H, Devous MD, Ross S, et al. The link between C-reactive protein and Alzheimer's disease among Mexican Americans. J Alzheimers Dis. 2013;34(3):701-6. PMID: 23254637.

13

Pavlik V, Massman P, Barber R, Doody R. Differences in the association of peripheral insulin and cognitive function in non-diabetic Alzheimer's disease cases and normal controls. J Alzheimers Dis. 2013;34(2):449-56. PMID: 23241558.

4

Proschan M, Ford CE, Cutler JA, Graumlich JF, Pavlik V, Cushman WC, et al. How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure? Stat Med. 2013;32(5):884-97. PMID: 22961832.

51

Rountree SD, Atri A, Lopez OL, Doody RS. Effectiveness of antidementia drugs in delaying Alzheimer's disease progression. Alzheimers Dement. 2013;9(3):338-45. PMID: 23102979.

23

Sabbagh M, Cummings J, Christensen D, Doody R, Farlow M, Liu L, et al. Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response. BMC Geriatr. 2013;13:56. PMID: 23742728.

10

Senanarong V, Harnphadungkit K, Poungvarin N, Vannasaeng S, Chongwisal S, Chakorn T, et al. The dementia and disability project in Thai elderly: Rational, design, methodology and early results. BMC Neurol. 2013;13:3. PMID: 23305293.

2

Spiegel R, Doody RS, Hendrix S, Kahle-Wrobleski K. Modeling the course of Alzheimer's disease to improve clinical trials: Symposium report. Alzheimers Res Ther. 2013;5(3):29. PMID: 23767782.

21

Szigeti K, Lal D, Li Y, Doody RS, Wilhelmsen K, Yan L, et al. Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease. J Alzheimers Dis. 2013;33(2):517-23. PMID: 23202439.

103

Vellas B, Carrillo MC, Sampaio C, Brashear HR, Siemers E, Hampel H, et al. Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force. Alzheimers Dement. 2013;9(4):438-44. PMID: 23809364.

44

Zhang X, Li L, Zhang X, Xie W, Li L, Yang D, et al. Prenatal hypoxia may aggravate the cognitive impairment and Alzheimer's disease neuropathology in APPSwe/PS1A246E transgenic mice. Neurobiol Aging. 2013;34(3):663-78. PMID: 22795785.

18

Atri A, Rountree SD, Lopez OL, Doody RS. Validity, significance, strengths, limitations, and evidentiary value of real-world clinical data for combination therapy in Alzheimer's disease: comparison of efficacy and effectiveness studies. Neurodegener Dis. 2012;10(1-4):170-4. PMID: 22327239.

26

Balsis S, Unger AA, Benge JF, Geraci L, Doody RS. Gaining precision on the Alzheimer's Disease Assessment Scale-cognitive: a comparison of item response theory-based scores and total scores. Alzheimers Dement. 2012;8(4):288-94. PMID: 22465173.

23

Doody RS, Cummings JL, Farlow MR. Reviewing the role of donepezil in the treatment of Alzheimer's disease. Curr Alzheimer Res. 2012;9(7):773-81. PMID: 22175653.

32

Doody RS, Geldmacher DS, Farlow MR, Sun Y, Moline M, Mackell J. Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: A subgroup analysis in patients already taking or not taking concomitant memantine. Dement Geriatr Cogn Disord. 2012;33(2-3):164-73. PMID: 22572767.

24

Grigoryan L, Pavlik VN, Hyman DJ. Predictors of antihypertensive medication adherence in two urban health-care systems. Am J Hypertens. 2012;25(7):735-8. PMID: 22441507.

14

Havins WN, Massman PJ, Doody R. Factor structure of the Geriatric Depression Scale and relationships with cognition and function in Alzheimer's disease. Dement Geriatr Cogn Disord. 2012;34(5-6):360-72. PMID: 23235472.

5

Hurko O, Black SE, Doody R, Doraiswamy PM, Gamst A, Kaye J, et al. The ADNI Publication Policy: Commensurate recognition of critical contributors who are not authors. Neuroimage. 2012;59(4):4196-200. PMID: 22100665.

16

Hyman DJ, Pavlik VN, Greisinger AJ, Chan W, Bayona J, Mansyur C, et al. Effect of a physician uncertainty reduction intervention on blood pressure in uncontrolled hypertensives--a cluster randomized trial. J Gen Intern Med. 2012;27(4):413-9. PMID: 22033742.

10

Li Y, Shaw CA, Sheffer I, Sule N, Powell SZ, Dawson B, et al. Integrated copy number and gene expression analysis detects a CREB1 association with Alzheimer's disease. Transl Psychiatry. 2012;2:e192. PMID: 23168992.

9

Lowe DA, Balsis S, Miller TM, Benge JF, Doody RS. Greater precision when measuring dementia severity: Establishing item parameters for the Clinical Dementia Rating Scale. Dement Geriatr Cogn Disord. 2012;34(2):128-34. PMID: 23006935.

0     

Pavlik V. Comment: Serum ceramides--a new biomarker for preclinical AD? Neurology. 2012;79(7):639. PMID: 22815553.

43

Rountree SD, Chan W, Pavlik VN, Darby EJ, Doody RS. Factors that influence survival in a probable Alzheimer disease cohort. Alzheimers Res Ther. 2012;4(3):16. PMID: 22594761.

127

Aisen PS, Andrieu S, Sampaio C, Carrillo M, Khachaturian ZS, Dubois B, et al. Report of the task force on designing clinical trials in early (predementia) AD. Neurology. 2011;76(3):280-6. PMID: 21178097.

11

Balsis S, Miller TM, Benge JF, Doody RS. Dementia staging across three different methods. Dement Geriatr Cogn Disord. 2011;31(5):328-33. PMID: 21555887.

11

Doody RS, Cole PE, Miller DS, Siemers E, Black R, Feldman H, et al. Global issues in drug development for Alzheimer's disease. Alzheimers Dement. 2011;7(2):197-207. PMID: 21414556.

7

Doody RS, Ferris SH, Salloway S, Meuser TM, Murthy AK, Li C, et al. Identifying amnestic mild cognitive impairment in primary care: A feasibility study. Clin Drug Investig. 2011;31(7):483-91. PMID: 21627337.

85

Mielke MM, Haughey NJ, Bandaru VV, Weinberg DD, Darby E, Zaidi N, et al. Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease. J Alzheimers Dis. 2011;27(2):259-69. PMID: 21841258.

7

Miller TM, Balsis S, Lowe DA, Benge JF, Doody RS. Item response theory reveals variability of functional impairment within clinical dementia rating scale stages. Dement Geriatr Cogn Disord. 2011;32(5):362-6. PMID: 22311305.

99

O'Bryant SE, Xiao G, Barber R, Huebinger R, Wilhelmsen K, Edwards M, et al. A blood-based screening tool for Alzheimer's disease that spans serum and plasma: Findings from TARC and ADNI. PLoS One. 2011;6(12):e28092. PMID: 22163278.

63

O'Bryant SE, Xiao G, Barber R, Reisch J, Hall J, Cullum CM, et al. A blood-based algorithm for the detection of Alzheimer's disease. Dement Geriatr Cogn Disord. 2011;32(1):55-62. PMID: 21865746.

3

Pavlik VN, Doody RS. Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment. Alzheimers Res Ther. 2011;3(5):30. PMID: 21999183.

30

Shaw CA, Li Y, Wiszniewska J, Chasse S, Zaidi SN, Jin W, et al. Olfactory copy number association with age at onset of Alzheimer disease. Neurology. 2011;76(15):1302-9. PMID: 21482944.

0     

Szigeti K, Doody RS. Should EOAD patients be included in clinical trials? Alzheimers Res Ther. 2011;3(1):4. PMID: 21345175.

0     

Szigeti K, Doody RS. Should persons with autosomal dominant AD be included in clinical trials? Authors' response. Alzheimers Res Ther. 2011;3(3):19. PMID: 21631907.

0     

Yeh YC, Lin KN, Chen WT, Lin CY, Chen TB, Wang PN. Functional disability profiles in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord. 2011;31(3):225-32. PMID: 21474931.

73

Zhang X, Heng X, Li T, Li L, Yang D, Zhang X, et al. Long-term treatment with lithium alleviates memory deficits and reduces amyloid-beta production in an aged Alzheimer's disease transgenic mouse model. J Alzheimers Dis. 2011;24(4):739-49. PMID: 21321394.

11

Doody RS, Ferris S, Salloway S, Yijun S, Goldman R, Yikang X, et al. Safety and tolerability of donepezil in mild cognitive impairment: Open-label extension study. Am J Alzheimers Dis Other Demen. 2010;25(2):155-9. PMID: 19949165.

72

Doody RS, Pavlik V, Massman P, Rountree S, Darby E, Chan W. Correction: Predicting progression of Alzheimer's disease. Alzheimers Res Ther. 2010;2(3):14. PMID: 20470369.

62

Doody RS, Pavlik V, Massman P, Rountree S, Darby E, Chan W. Predicting progression of Alzheimer's disease. Alzheimers Res Ther. 2010;2(1):2. PMID: 20178566.

0     

Doody RS. Clinical trials in AD. Rinsho Shinkeigaku. 2010;50(11):835. PMID: 21921461.

6

Doody RS. Evolving early (pre-dementia) Alzheimer's disease trials: Suit the outcomes to the population and study design. J Nutr Health Aging. 2010;14(4):299-302. PMID: 20306000.

303

Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, et al. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology. 2010;74(12):956-64. PMID: 20200346.

43

Kunik ME, Snow AL, Davila JA, McNeese T, Steele AB, Balasubramanyam V, et al. Consequences of aggressive behavior in patients with dementia. J Neuropsychiatry Clin Neurosci. 2010;22(1):40-7. PMID: 20160208.

78

Kunik ME, Snow AL, Davila JA, Steele AB, Balasubramanyam V, Doody RS, et al. Causes of aggressive behavior in patients with dementia. J Clin Psychiatry. 2010;71(9):1145-52. PMID: 20361896.

17

Kwon OD, Khaleeq A, Chan W, Pavlik VN, Doody RS. Apolipoprotein E polymorphism and age at onset of Alzheimer's disease in a quadriethnic sample. Dement Geriatr Cogn Disord. 2010;30(6):486-91. PMID: 21252542.

177

O'Bryant SE, Xiao G, Barber R, Reisch J, Doody R, Fairchild T, et al. A serum protein-based algorithm for the detection of Alzheimer disease. Arch Neurol. 2010;67(9):1077-81. PMID: 20837851.

0     

Wolk DA, Dickerson BC, Alzheimer's Disease Neuroimaging Initiative. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc Natl Acad Sci U S A. 2010;107(22):10256-61. PMID: 20479234.

41

Benge JF, Balsis S, Geraci L, Massman PJ, Doody RS. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease? Dement Geriatr Cogn Disord. 2009;28(1):63-9. PMID: 19641319.

161

Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, et al. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Neurology. 2009;72(18):1555-61. PMID: 19176895.

4

Doody RS. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: It is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease. Alzheimers Dement. 2009;5(2):133-6. PMID: 19328443.

9

Doody RS. Dimebon as a potential therapy for Alzheimer's disease. CNS Spectr. 2009;14(8 Suppl 7):14-6; discussion 16-8. PMID: 19890242.

0     

Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, Dwyer J, et al. A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement. 2009;5(2):85-92. PMID: 19328434.

11

Na HR, Lee SH, Lee JS, Doody RS, Kim SY. Korean version of the Baylor Profound Mental Status Examination: A brief staging measure for patients with severe Alzheimer's disease. Dement Geriatr Cogn Disord. 2009;27(1):69-75. PMID: 19145080.

24

Pavlik VN, Doody RS, Rountree SD, Darby EJ. Vitamin E use is associated with improved survival in an Alzheimer's disease cohort. Dement Geriatr Cogn Disord. 2009;28(6):536-40. PMID: 20016184.

16

Pavlik VN, Greisinger AJ, Pool J, Haidet P, Hyman DJ. Does reducing physician uncertainty improve hypertension control? Rationale and methods. Circ Cardiovasc Qual Outcomes. 2009;2(3):257-63. PMID: 20031846.

0     

Rountree SD, Chan W, Pavlik VN, Darby EJ, Siddiqui S, Doody RS. Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease. Alzheimers Res Ther. 2009;1(2):7. PMID: 19845950.

37

Rustveld LO, Pavlik VN, Jibaja-Weiss ML, Kline KN, Gossey JT, Volk RJ. Adherence to diabetes self-care behaviors in English- and Spanish-speaking Hispanic men. Patient Prefer Adherence. 2009;3:123-30. PMID: 19936154.

547

Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, et al. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology. 2009;73(24):2061-70. PMID: 19923550.

18

Schneider LS, Raman R, Schmitt FA, Doody RS, Insel P, Clark CM, et al. Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials. Alzheimer Dis Assoc Disord. 2009;23(3):260-7. PMID: 19812469.

8

Snyder PJ, Papp KV, Bartkowiak J, Jackson CE, Doody RS. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: The role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors. Alzheimers Dement. 2009;5(2):122-4. PMID: 19328439.

28

Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R. Safety and tolerability of donepezil at doses up to 20 mg/day: Results from a pilot study in patients with Alzheimer's disease. Drugs Aging. 2008;25(2):163-74. PMID: 18257603.

386

Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, et al. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: A randomized, double-blind, placebo-controlled study. Lancet. 2008;372(9634):207-15. PMID: 18640457.

73

Doody RS, Tariot PN, Pfeiffer E, Olin JT, Graham SM. Meta-analysis of six-month memantine trials in Alzheimer's disease. Alzheimers Dement. 2008;3(1):7-17.

10

Doody RS. Cholinesterase inhibitors and memantine: Best practices. CNS Spectr. 2008;13(10 Suppl 16):34-5. PMID: 18955960.

16

Doody RS. We should not distinguish between symptomatic and disease-modifying treatments in Alzheimer's disease drug development. Alzheimers Dement. 2008;4(1 Suppl 1):S21-5. PMID: 18631995.

108

Jack CR, Jr, Petersen RC, Grundman M, Jin S, Gamst A, et al. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging. 2008;29(9):1285-95. PMID: 17452062.

55

Jones RW, Kivipelto M, Feldman H, Sparks L, Doody R, Waters DD, et al. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): Design and baseline characteristics. Alzheimers Dement. 2008;4(2):145-53. PMID: 18631958.

21

Kelly PA, Dyer CB, Pavlik V, Doody R, Jogerst G. Exploring self-neglect in older adults: Preliminary findings of the self-neglect severity scale and next steps. J Am Geriatr Soc. 2008;56 Suppl 2:S253-60. PMID: 19016968.

40

Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, et al. A roadmap for the prevention of dementia: The inaugural Leon Thal Symposium. Alzheimers Dement. 2008;4(3):156-63. PMID: 18631960.

21

Naik AD, Teal CR, Pavlik VN, Dyer CB, McCullough LB. Conceptual challenges and practical approaches to screening capacity for self-care and protection in vulnerable older adults. J Am Geriatr Soc. 2008;56 Suppl 2:S266-70. PMID: 19016970.

351

O'Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ, et al. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study. Arch Neurol. 2008;65(8):1091-5. PMID: 18695059.

0     

Rustveld LO, Pavlik VN, Doody RS. Hyperinsulinemia, type 2 diabetes mellitus and cognitive decline. TPHA Journal. 2008;60:17-22.

81

Yan JH, Rountree S, Massman P, Doody RS, Li H. Alzheimer's disease and mild cognitive impairment deteriorate fine movement control. J Psychiatr Res. 2008;42(14):1203-12. PMID: 18280503.

30

Atchison TB, Massman PJ, Doody RS. Baseline cognitive function predicts rate of decline in basic-care abilities of individuals with dementia of the Alzheimer's type. Arch Clin Neuropsychol. 2007;22(1):99-107. PMID: 17174522.

55

Barnes AS, Goodrick GK, Pavlik V, Markesino J, Laws DY, Taylor WC. Weight loss maintenance in African-American women: Focus group results and questionnaire development. J Gen Intern Med. 2007;22(7):915-22. PMID: 17415617.

182

Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, et al. Donepezil preserves cognition and global function in patients with severe Alzheimer disease. Neurology. 2007;69(5):459-69. PMID: 17664405.

17

Brown AE, Pavlik VN, Shegog R, Whitney SN, Friedman LC, Romero C, et al. Association of spirituality and sobriety during a behavioral spirituality intervention for Twelve Step (TS) recovery. Am J Drug Alcohol Abuse. 2007;33(4):611-7. PMID: 17668347.

222

Cummings JL, Doody R, Clark C. Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology. 2007;69(16):1622-34. PMID: 17938373.

135

Hyman DJ, Pavlik VN, Taylor WC, Goodrick GK, Moye L. Simultaneous vs sequential counseling for multiple behavior change. Arch Intern Med. 2007;167(11):1152-8. PMID: 17563023.

20

Lin G, Spann S, Hyman D, Pavlik V. Climate amenity and BMI. Obesity (Silver Spring). 2007;15(8):2120-7. PMID: 17712131.

21

Park KW, Pavlik VN, Rountree SD, Darby EJ, Doody RS. Is functional decline necessary for a diagnosis of Alzheimer's disease? Dement Geriatr Cogn Disord. 2007;24(5):375-9. PMID: 17914262.

63

Rountree SD, Waring SC, Chan WC, Lupo PJ, Darby EJ, Doody RS. Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: Prognosis and conversion to dementia. Dement Geriatr Cogn Disord. 2007;24(6):476-82. PMID: 17992015.

132

Volk RJ, Hawley ST, Kneuper S, Holden EW, Stroud LA, Cooper CP, et al. Trials of decision aids for prostate cancer screening: a systematic review. Am J Prev Med. 2007;33(5):428-34. PMID: 17950409.

24

Dyer CB, Kelly PA, Pavlik VN, Lee J, Doody RS, Regev T, et al. The making of a self-neglect severity scale. J Elder Abuse Negl. 2006;18(4):13-23. PMID: 17972656.

0     

Fillit HM, Doody RS, Binaso K, Crooks GM, Ferris SH, Farlow MR, et al. Recommendations for best practices in the treatment of Alzheimer's disease in managed care. Am J Geriatr Pharmacother. 2006;4 Suppl A:S9-S24; quiz S25-S28. PMID: 17157793.

34

Gavagan TF, Smart K, Palacio H, Dyer C, Greenberg S, Sirbaugh P, et al. Hurricane Katrina: Medical response at the Houston Astrodome/Reliant Center Complex. South Med J. 2006;99(9):933-9. PMID: 17004527.

78

Geldmacher DS, Frolich L, Doody RS, Erkinjuntti T, Vellas B, Jones RW, et al. Realistic expectations for treatment success in Alzheimer's disease. J Nutr Health Aging. 2006;10(5):417-29. PMID: 17066215.

43

Pavlik VN, Doody RS, Massman PJ, Chan W. Influence of premorbid IQ and education on progression of Alzheimer's disease. Dement Geriatr Cogn Disord. 2006;22(4):367-77. PMID: 16954693.

136

Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Arch Neurol. 2006;63(1):49-54. PMID: 16401736.

29

Schneider LS, Clark CM, Doody R, Ferris SH, Morris JC, Raman R, et al. ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions. Alzheimer Dis Assoc Disord. 2006;20(4 Suppl 3):S124-38. PMID: 17135806.

116

Spann SJ, Nutting PA, Galliher JM, Peterson KA, Pavlik VN, Dickinson LM, et al. Management of type 2 diabetes in the primary care setting: a practice-based research network study. Ann Fam Med. 2006;4(1):23-31. PMID: 16449393.

0     

Bitondo Dyer C, Toronjo C, Cunningham M, Festa NA, Pavlik VN, Hyman DJ, et al. The key elements of elder neglect:a survey of adult protective service workers. J Elder Abuse Negl. 2005;17(4):1-10. PMID: 17050489.

52

Doody R, Pavlik V, Massman P, Kenan M, Yeh S, Powell S, et al. Changing patient characteristics and survival experience in an Alzheimer's center patient cohort. Dement Geriatr Cogn Disord. 2005;20(2-3):198-208. PMID: 16088145.

13

Doody RS. Refining treatment guidelines in Alzheimer's disease. Geriatrics. 2005;Suppl:14-20. PMID: 16025771.

52

Graham DP, Kunik ME, Doody R, Snow AL. Self-reported awareness of performance in dementia. Brain Res Cogn Brain Res. 2005;25(1):144-52. PMID: 15919186.

67

Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Arch Neurol. 2005;62(3):454-9. PMID: 15767511.

54

Pavlik VN, Hyman DJ, Doody R. Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III). Neuroepidemiology. 2005;24(1-2):42-50. PMID: 15459509.

1340

Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352(23):2379-88. PMID: 15829527.

80

Roman GC, Wilkinson DG, Doody RS, Black SE, Salloway SP, Schindler RJ. Donepezil in vascular dementia: Combined analysis of two large-scale clinical trials. Dement Geriatr Cogn Disord. 2005;20(6):338-44. PMID: 16192723.

15

Snow AL, Graham DP, Molinari VA, Orengo CA, Doody RS, Norris MP, et al. Factors affecting deficit awareness in persons with dementia. Dement Geriatr Cogn Disord. 2005;20(2-3):133-9. PMID: 16020941.

53

Snow AL, Kunik ME, Molinari VA, Orengo CA, Doody R, Graham DP, et al. Accuracy of self-reported depression in persons with dementia. J Am Geriatr Soc. 2005;53(3):389-96. PMID: 15743279.

72

Waring SC, Doody RS, Pavlik VN, Massman PJ, Chan W. Survival among patients with dementia from a large multi-ethnic population. Alzheimer Dis Assoc Disord. 2005;19(4):178-83. PMID: 16327343.

44

Doody R, Wirth Y, Schmitt F, Mobius HJ. Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease. Dement Geriatr Cogn Disord. 2004;18(2):227-32. PMID: 15256834.

33

Doody RS, Dunn JK, Huang E, Azher S, Kataki M. A method for estimating duration of illness in Alzheimer's disease. Dement Geriatr Cogn Disord. 2004;17(1-2):1-4. PMID: 14560058.

52

Graham DP, Cully JA, Snow AL, Massman P, Doody R. The Alzheimer's Disease Assessment Scale-Cognitive subscale: Normative data for older adult controls. Alzheimer Dis Assoc Disord. 2004;18(4):236-40. PMID: 15592137.

685

Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004;61(1):59-66. PMID: 14732621.

4

Pavlik VN, Hyman DJ, Wendt JA, Orengo C. Association of a culturally defined syndrome (nervios) with chest pain and DSM-IV affective disorders in Hispanic patients referred for cardiac stress testing. Ethn Dis. 2004;14(4):505-14. PMID: 15724769.

33

Snow AL, Norris MP, Doody R, Molinari VA, Orengo CA, Kunik ME. Dementia Deficits Scale. Rating self-awareness of deficits. Alzheimer Dis Assoc Disord. 2004;18(1):22-31. PMID: 15198084.

285

Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, et al. Cerebrospinal fluid tau and beta-amyloid: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol. 2003;60(12):1696-702. PMID: 14676043.

14

Davis RN, Massman PJ, Doody RS. Effects of blood pressure on neuropsychological functioning in Alzheimer's disease. Arch Clin Neuropsychol. 2003;18(1):19-32. PMID: 14591475.

12

Davis RN, Massman PJ, Doody RS. WAIS-R factor structure in Alzheimer's disease patients: A comparison of alternative models and an assessment of their generalizability. Psychol Aging. 2003;18(4):836-43. PMID: 14692868.

66

Doody RS. Current treatments for Alzheimer's disease: Cholinesterase inhibitors. J Clin Psychiatry. 2003;64 Suppl 9:11-7. PMID: 12934969.

6

Doody RS. Update on Alzheimer drugs (donepezil). Neurologist. 2003;9(5):225-9. PMID: 12971832.

10

Hyman DJ, Pavlik VN. Uncontrolled hypertension as a risk for coronary artery disease: Patient characteristics and the role of physician intervention. Curr Atheroscler Rep. 2003;5(2):131-8. PMID: 12573199.

68

Pavlik VN, de Moraes SA, Szklo M, Knopman DS, Mosley TH, Jr, et al. Relation between cognitive function and mortality in middle-aged adults: The atherosclerosis risk in communities study. Am J Epidemiol. 2003;157(4):327-34. PMID: 12578803.

10

Pavlik VN, Hyman DJ. How well are we managing and monitoring high blood pressure? Curr Opin Nephrol Hypertens. 2003;12(3):299-304. PMID: 12698069.

1537

Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ, et al. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med. 2003;348(14):1333-41. PMID: 12672860.

0     

Smith RG, Roher AE, Appel SH, Doody RS, Killian JM, Corey-Bloom J, et al. Autonomic sudomotor dysfunction in Alzheimer's disease. Curr Med Chem - Imun Endoc Metab Agents. 2003;3(1):77-84.

3

Wayne DB, Greenberg SB, Pavlik VN, Helmer DA, Hyman DJ. Ambulatory internal medicine education: Use of an urgent care center. South Med J. 2003;96(9):876-9. PMID: 14513983.

273

Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, et al. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology. 2003;61(4):479-86. PMID: 12939421.

44

Harrell R, Toronjo CH, McLaughlin J, Pavlik VN, Hyman DJ, Dyer CB. How geriatricians identify elder abuse and neglect. Am J Med Sci. 2002;323(1):34-8. PMID: 11814140.

0     

Hyman DJ, Pavlik VN. Hypertension control in the United States: Role of physician noncompliance. Cleve Clin J Med. 2002;69(10):793-9.

30

Hyman DJ, Pavlik VN. Poor hypertension control: Let's stop blaming the patients. Cleve Clin J Med. 2002;69(10):793-9. PMID: 12371802.

12

Kusek JW, Ahrens A, Burrows PK, Clarke HS, Foster HE, Hanson K, et al. Recruitment for a clinical trial of drug treatment for benign prostatic hyperplasia. Urology. 2002;59(1):63-7. PMID: 11796283.

21

Li D, Ronson B, Guo M, Liu S, Bishop JS, Van Echo DA, et al. Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer. Cancer Res. 2002;62(14):4023-8. PMID: 12124336.

13

Poston WS, Haddock CK, Spertus J, Catanese DM, Pavlik VN, Hyman DJ, et al. Physical activity does not mitigate G-protein-related genetic risk for obesity in individuals of African descent. Eat Weight Disord. 2002;7(1):68-71. PMID: 11930987.

37

Quinn J, Moore M, Benson DF, Clark CM, Doody R, Jagust W, et al. A videotaped CIBIC for dementia patients: Validity and reliability in a simulated clinical trial. Neurology. 2002;58(3):433-7. PMID: 11839844.

35

Weiner MF, Doody RS, Sairam R, Foster B, Liao TY. Prevalence and incidence of major depressive disorder in Alzheimer's disease: findings from two databases. Dement Geriatr Cogn Disord. 2002;13(1):8-12. PMID: 11731709.

167

Davis RN, Massman PJ, Doody RS. Cognitive intervention in Alzheimer disease: a randomized placebo-controlled study. Alzheimer Dis Assoc Disord. 2001;15(1):1-9. PMID: 11236819.

105

Doody RS, Dunn JK, Clark CM, Farlow M, Foster NL, Liao T, et al. Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease. Dement Geriatr Cogn Disord. 2001;12(4):295-300. PMID: 11351141.

317

Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol. 2001;58(3):427-33. PMID: 11255446.

136

Doody RS, Massman P, Dunn JK. A method for estimating progression rates in Alzheimer disease. Arch Neurol. 2001;58(3):449-54. PMID: 11255449.

714

Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, et al. Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1154-66. PMID: 11342679.

656

Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345(7):479-86. PMID: 11519501.

26

Li D, Shugert E, Guo M, Bishop JS, O'Malley BW, Jr. Combination nonviral interleukin 2 and interleukin 12 gene therapy for head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2001;127(11):1319-24. PMID: 11701067.

18

Li D, Zeiders JW, Liu S, Guo M, Xu Y, Bishop JS, et al. Combination nonviral cytokine gene therapy for head and neck cancer. Laryngoscope. 2001;111(5):815-20. PMID: 11368072.

446

Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, et al. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology. 2001;57(3):481-8. PMID: 11502917.

88

Pavlik VN, Hyman DJ, Festa NA, Bitondo Dyer C. Quantifying the problem of abuse and neglect in adults--analysis of a statewide database. J Am Geriatr Soc. 2001;49(1):45-8. PMID: 11207841.

3549

Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58(12):1985-92. PMID: 11735772.

27

Poston WS, Pavlik VN, Hyman DJ, Ogbonnaya K, Hanis CL, Haddock CK, et al. Genetic bottlenecks, perceived racism, and hypertension risk among African Americans and first-generation African immigrants. J Hum Hypertens. 2001;15(5):341-51. PMID: 11378837.

23

Sharma MD, Pavlik VN. Dyslipidaemia in African Americans, Hispanics and whites with type 2 diabetes mellitus and hypertension. Diabetes Obes Metab. 2001;3(1):41-5. PMID: 11213598.

0     

Tangalos E, Doody R, Tariot P. Alzheimer's disease in long-term care: Maximizing treatment options. J Am Med Dir Assoc. 2001;2(4):H17-20. PMID: 12812557.

9

Bishop JS, Thull NM, Matar M, Quezada A, Munger WE, Batten TL, et al. Antitumoral effect of a nonviral interleukin-2 gene therapy is enhanced by combination with 5-fluorouracil. Cancer Gene Ther. 2000;7(8):1165-71. PMID: 10975677.

25

Doody RS, Azher SN, Haykal HA, Dunn JK, Liao T, Schneider L. Does APO epsilon4 correlate with MRI changes in Alzheimer's disease? J Neurol Neurosurg Psychiatry. 2000;69(5):668-71. PMID: 11032626.

38

Doody RS. Mortality from pneumonia and hip fractures in patients with advanced dementia. Jama. 2000;284(19):2447; author reply 2448. PMID: 11074768.

0     

Doody RS. The issue of representation in brain research. Brain Cogn. 2000;42(1):26-8. PMID: 10739589.

242

Dyer CB, Pavlik VN, Murphy KP, Hyman DJ. The high prevalence of depression and dementia in elder abuse or neglect. J Am Geriatr Soc. 2000;48(2):205-8. PMID: 10682951.

10

Hanna PA, Doody RS. Alien limb sign. Adv Neurol. 2000;82:135-45. PMID: 10624477.

14

Hyman DJ, Ogbonnaya K, Pavlik VN, Poston WS, Ho K. Lower hypertension prevalence in first-generation African immigrants compared to US-born African Americans. Ethn Dis. 2000;10(3):343-9. PMID: 11110350.

39

Hyman DJ, Ogbonnaya K, Taylor AA, Ho K, Pavlik VN. Ethnic differences in nocturnal blood pressure decline in treated hypertensives. Am J Hypertens. 2000;13(8):884-91. PMID: 10950396.

0     

Hyman DJ, Pavlik VN, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens (Greenwich). 2000;2(5):324-30. PMID: 11416669.

332

Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: Blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160(15):2281-6. PMID: 10927724.

37

Mendiratta SK, Quezada A, Matar M, Thull NM, Bishop JS, Nordstrom JL, et al. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma. Hum Gene Ther. 2000;11(13):1851-62. PMID: 10986558.

862

Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. Jama. 2000;283(8):1007-15. PMID: 10697060.

0     

Pavlik VN, Hyman DJ, Toronjo C. Comparison of automated and mercury column blood pressure measurements in health care settings. J Clin Hypertens (Greenwich). 2000;2(2):81-6. PMID: 11416630.

227

Rogers SL, Doody RS, Pratt RD, Ieni JR. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: Final analysis of a US multicentre open-label study. Eur Neuropsychopharmacol. 2000;10(3):195-203. PMID: 10793322.

18

Balasubramanyam A, McKay S, Nadkarni P, Rajan AS, Garza A, Pavlik V, et al. Ethnicity affects the postprandial regulation of glycogenolysis. Am J Physiol. 1999;277(5 Pt 1):E905-14. PMID: 10567019.

112

Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V. New profiles of diabetic ketoacidosis: Type 1 vs type 2 diabetes and the effect of ethnicity. Arch Intern Med. 1999;159(19):2317-22. PMID: 10547172.

15

Blezinger P, Yin G, Xie L, Wang J, Matar M, Bishop JS, et al. Intravenous delivery of an endostatin gene complexed in cationic lipid inhibits systemic angiogenesis and tumor growth in murine models. Angiogenesis. 1999;3(3):205-10. PMID: 14517419.

16

Doody RS, Strehlow SL, Massman PJ, Feher EP, Clark C, Roy JR. Baylor profound mental status examination: A brief staging measure for profoundly demented Alzheimer disease patients. Alzheimer Dis Assoc Disord. 1999;13(1):53-9. PMID: 10192643.

21

Doody RS, Vacca JL, Massman PJ, Liao TY. The influence of handedness on the clinical presentation and neuropsychology of Alzheimer disease. Arch Neurol. 1999;56(9):1133-7. PMID: 10488815.

20

Doody RS. Clinical benefits of a new piperidine-class AChE inhibitor. Eur Neuropsychopharmacol. 1999;9 Suppl 2:S69-77. PMID: 10332937.

69

Doody RS. Clinical profile of donepezil in the treatment of Alzheimer's disease. Gerontology. 1999;45 Suppl 1:23-32. PMID: 9876215.

21

Doody RS. Therapeutic standards in Alzheimer disease. Alzheimer Dis Assoc Disord. 1999;13 Suppl 2:S20-6. PMID: 10622675.

25

Dyer CB, Gleason MS, Murphy KP, Pavlik VN, Portal B, Regev T, et al. Treating elder neglect: collaboration between a geriatrics assessment team and adult protective services. South Med J. 1999;92(2):242-4. PMID: 10071677.

8

Dyer CB, Pavlik V, Portal B, Hyman DJ, Barth J, Murphy KP, et al. A case series of abused or neglected elders treated by an interdisciplinary geriatric team. J Elder Abuse Negl. 1999;9:131-9.

39

Li D, Jiang W, Bishop JS, Ralston R, O'Malley BW, Jr. Combination surgery and nonviral interleukin 2 gene therapy for head and neck cancer. Clin Cancer Res. 1999;5(6):1551-6. PMID: 10389944.

42

Coleman M, Muller S, Quezada A, Mendiratta SK, Wang J, Thull NM, et al. Nonviral interferon alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune response. Hum Gene Ther. 1998;9(15):2223-30. PMID: 9794206.

2

Doody R, Whitehouse PJ, Chen Q, Wang L, Wu Q, Rosser M, et al. Alzheimer disease-related activities in China: a report from the International Working Group on the Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1998;12(4):263-5. PMID: 9876954.

42

Doody RS, Massman PJ, Mawad M, Nance M. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia. Neuropsychiatry Neuropsychol Behav Neurol. 1998;11(4):191-9. PMID: 9845410.

10

Hyman DJ, Pavlik VN, Vallbona C, Dunn JK, Louis K, Dewey CM, et al. Blood pressure measurement and antihypertensive treatment in a low-income African-American population. Am J Public Health. 1998;88(2):292-4. PMID: 9491026.

636

Rogers SL, Doody RS, Mohs RC, Friedhoff LT. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med. 1998;158(9):1021-31. PMID: 9588436.

1404

Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology. 1998;50(1):136-45. PMID: 9443470.

2

Amaducci L, Baldereschi M, Doody R, Chandra V, Gaines AD. Cultural issues in the clinical diagnosis of Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:19-21. PMID: 9305509.

2

Antuono P, Doody R, Gilman S, Huff J, Scheltens P, Ueda K, et al. Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:22-5. PMID: 9305510.

35

Clark CM, Ewbank D, Lerner A, Doody R, Henderson VW, Panisset M, et al. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease. Neurology. 1997;49(1):70-5. PMID: 9222172.

6

Doody RS. Treatment of Alzheimer's disease. Neurologist. 1997;3(6):333-43.

35

Pavlik VN, Hyman DJ, Vallbona C, Toronjo C, Louis K. Hypertension awareness and control in an inner-city African-American sample. J Hum Hypertens. 1997;11(5):277-83. PMID: 9205933.

96

Perkins P, Annegers JF, Doody RS, Cooke N, Aday L, Vernon SW. Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees. Neurology. 1997;49(1):44-50. PMID: 9222168.

79

Reisberg B, Schneider L, Doody R, Anand R, Feldman H, Haraguchi H, et al. Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:8-18. PMID: 9305508.

23

Sabbagh MN, Lynn P, Jhingran S, Massman P, Villanueva-Meyer J, Olup J, et al. Correlations between SPECT regional cerebral blood flow and psychometric testing in patients with Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1997;9(1):68-74. PMID: 9017531.

519

Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, et al. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S22-32. PMID: 9236949.

35

Strite D, Massman PJ, Cooke N, Doody RS. Neuropsychological asymmetry in Alzheimer's disease: Verbal versus visuoconstructional deficits across stages of dementia. J Int Neuropsychol Soc. 1997;3(5):420-7. PMID: 9322400.

34

Thal LJ, Carta A, Doody R, Leber P, Mohs R, Schneider L, et al. Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:46-9. PMID: 9305516.

0     

Bishop JS, Guy-Caffey JK, Ojwang JO, Smith SR, Hogan ME, Cossum PA, et al. Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide. J Biol Chem. 1996;271(10):5698-703. PMID: 8621435.

0     

Hanson CI, Spears W, Jenkins K, Stoner D, "All Kids Count" Epidemiology Working Group (included Pavlik V). Immunization prevalence rates for infants in a large urban center: Houston/Harris County. Tex Med. 1996;92:66-71.

0     

Kadmon D, Weinberg AD, Williams RH, Pavlik VN, Cooper P, Migliore PJ. Pitfalls in interpreting prostate specific antigen velocity. J Urol. 1996;155(5):1655-7. PMID: 8627846.

0     

Kataki M, Winikates J, Kirkpatrick J, Doody RS. Longitudinal study of aphasia in Creutzfeldt-Jakob disease. Neuropsychiatry Neuropsychol Behav Neurol. 1996;9(4):284-7.

21

Massman PJ, Doody RS. Hemispheric asymmetry in Alzheimer's disease is apparent in motor functioning. J Clin Exp Neuropsychol. 1996;18(1):110-21. PMID: 8926290.

66

Massman PJ, Kreiter KT, Jankovic J, Doody RS. Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer's disease. Neurology. 1996;46(3):720-6. PMID: 8618672.

41

Olin JT, Schneider LS, Doody RS, Clark CM, Ferris SH, Morris JC, et al. Clinical evaluation of global change in Alzheimer's disease: identifying consensus. J Geriatr Psychiatry Neurol. 1996;9(4):176-80. PMID: 8970010.

16

Pavlik VN, Hyman DJ, Vallbona C, Dunn JK, Louis K, Dewey CM, et al. Response rates to random digit dialing for recruiting participants to an onsite health study. Public Health Rep. 1996;111(5):444-50. PMID: 8837634.

24

Pavlik VN, Hyman DJ, Vallbona C. Hypertension control in multi-ethnic primary care clinics. J Hum Hypertens. 1996;10 Suppl 3:S19-23. PMID: 8872819.

1

Pavlik VN, Nichaman MZ, Vallbona C. NIDDM incidence in a tri-ethnic population of diagnosed hypertensives. Ethn Dis. 1996;6(3-4):213-23. PMID: 9086311.

63

Doody RS, Massman P, Mahurin R, Law S. Positive and negative neuropsychiatric features in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1995;7(1):54-60. PMID: 7711492.

0     

Guy-Caffey JK, Bodepudi V, Bishop JS, Jayaraman K, Chaudhary N. Novel polyaminolipids enhance the cellular uptake of oligonucleotides. J Biol Chem. 1995;270(52):31391-6. PMID: 8537413.

62

Kotrla KJ, Chacko RC, Harper RG, Doody R. Clinical variables associated with psychosis in Alzheimer's disease. Am J Psychiatry. 1995;152(9):1377-9. PMID: 7653698.

107

Kotrla KJ, Chacko RC, Harper RG, Jhingran S, Doody R. SPECT findings on psychosis in Alzheimer's disease. Am J Psychiatry. 1995;152(10):1470-5. PMID: 7573586.

21

Shaibani A, Sabbagh M, Doody RS. Laughter and crying in neurologic disorders. Neuropsychiatry Neuropsychol Behav Neurol. 1994;7(4):243-50.

13

Aruffo JF, Coverdale JH, Pavlik VN, Vallbona C. AIDS knowledge in minorities: Significance of locus of control. Am J Prev Med. 1993;9(1):15-20. PMID: 8439432.

19

Baker SB, Vallbona C, Pavlik V, Fasser CE, Armbruster M, McCray R, et al. A diabetes control program in a public health care setting. Public Health Rep. 1993;108(5):595-605. PMID: 8210258.

7

Doody RS. A reappraisal of localization theory with reference to aphasia. Part 1: Historical considerations. Brain Lang. 1993;44(3):296-326. PMID: 8513406.

2

Doody RS. A reappraisal of localization theory with reference to aphasia. Part 2: Language theories from outside neurology. Brain Lang. 1993;44(3):327-48. PMID: 8513407.

610

Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, et al. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. N Engl J Med. 1992;327(18):1253-9. PMID: 1406817.

8

Doody RS, Hrachovy RA, Feher EP. Recurrent fluent aphasia associated with a seizure focus. Brain Lang. 1992;42(4):419-30. PMID: 1611466.

132

Doody RS, Jankovic J. The alien hand and related signs. J Neurol Neurosurg Psychiatry. 1992;55(9):806-10. PMID: 1402972.

0     

Doody RS. Sense and non-sense: Dissemination and empiricism in practice. Ethos. 1992;20(2):220-9.

147

Feher EP, Mahurin RK, Doody RS, Cooke N, Sims J, Pirozzolo FJ. Establishing the limits of the Mini-Mental State. Examination of 'subtests'. Arch Neurol. 1992;49(1):87-92. PMID: 1728269.

10

Vallbona C, Pavlik V. Advances in the community control of hypertension: from epidemiology to primary care practice. J Hypertens Suppl. 1992;10(7):S51-7. PMID: 1291657.

0     

Doody RS. Aphasia as postmodern (anthropological) discourse. J Anthropol Res. 1991;47(3):285-303.

4

Feher EP, Doody RS, Whitehead J, Pirozzolo FJ. Progressive nonfluent aphasia with dementia: A case report. J Geriatr Psychiatry Neurol. 1991;4(4):236-40. PMID: 1789913.

4

Pavlik VN, Rankin BB, Vallbona C, Bacon RJ, Tristan MP. Factors related to medical school application and acceptance in minority summer enrichment program students. J Natl Med Assoc. 1991;83(7):628-32. PMID: 1920520.

2

Doody RS, Rosenfield DB. Spasmodic dysphonia associated with palatal myoclonus. Ear Nose Throat J. 1990;69(12):829-32. PMID: 2079007.

2

Feher EP, Doody R, Pirozzolo FJ, Appel SH. Mental status assessment of insight and judgment. Clin Geriatr Med. 1989;5(3):477-98. PMID: 2680029.

1

Yusim S, Vallbona C, Pavlik V, Sanford S, Baron A, Merrill J. Failures in comprehensive diagnosis by senior medical students. J Med Educ. 1984;59(10):838-40. PMID: 6481784.

155

Ornish D, Scherwitz LW, Doody RS, Kesten D, McLanahan SM, Brown SE, et al. Effects of stress management training and dietary changes in treating ischemic heart disease. Jama. 1983;249(1):54-9. PMID: 6336794.

4

Doody RS, Grose NP. The family medical history: Assessing patient understanding of diabetes mellitus. Diabetes Care. 1981;4(2):285-8. PMID: 7215084.

3

Tristan MP, Pavlik VN, Rankin BB, Lester J, Vallbona C. Review of a program for premedical minority students. Tex Med. 1981;77(3):51-4. PMID: 7209813.